BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month
CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
News
Cocrystal Pharma Provides Update on its COVID-19 Antiviral Discovery and Development Programs
BOTHELL, Wash., May 03, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company...
Neoleukin Therapeutics Announces Appointment of Priti Patel, M.D., M.S., as Chief Medical Officer
SEATTLE, May 03, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results
-- First U.S. commercial sales of IMCIVREE™ (setmelanotide) completed late in first quarter – -- Late-breaking data presentations at ENDO...
Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
- Data Showed AAVHSCs Edited Human Retinal Cell Types Across Two Targets - - Demonstrated 11 AAVHSC Capsids Crossed Blood-Retinal...
French National Cancer Institute and XBiotech Join forces to Conduct Innovative Phase II/III Adaptive Multicenter Clinical Study for XBiotech’s New Cancer Drug for Colorectal Cancer
XBiotech to Supply INSERM its New Drug to Use in Combination Therapy for Treating Advanced Colorectal CancerAUSTIN, Texas, May 03,...
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Increases Its Quarterly Dividend to $0.30 per Share
8.8% Increase in Fiscal 2021 Sales18.4% Increase in Fiscal 2021 Net Income9.7% Increase in Fiscal 2021 Reorder Sales DELRAY BEACH,...
Kymera Therapeutics Presents Positive Late-Breaking Data from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology 2021 Annual Meeting
Data provide further evidence for the central role of IRAK4 in inflammation in hidradenitis suppurativa and support both the degrader...
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences
Employees who have found depression relief with NeuroStar Advanced Therapy for Mental Health use their voice to help othersMALVERN, Pa.,...
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
Company Prepares for Next Stage of GrowthFRAMINGHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch”...
Mydecine Reports Full Year 2020 Financial Results and Provides Business Update
Positioned as Leader in Emerging Psychedelic Therapeutics Market through Robust IP Portfolio, Novel Clinical Trials and Evolving Proprietary Technology Strengthened...
ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by the United States Patent and Trademark Office
YONKERS, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2
COVAXIN effectively neutralizes Brazil variant along with UK variant and India double mutant variantPotential effectiveness against multiple variants reduces the...
AIM ImmunoTech CEO Thomas K. Equels Participates in Fireside Chat with Ascendiant Capital Markets Analyst Ed Woo
OCALA, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces that Thomas K. Equels, CEO...
Dosecann Launches Industry-Leading, High-Potency Topical: Dosecann Daily Relief CBD Cream
Dosecann Daily Relief CBD Cream Dosecann Daily Relief CBD Cream TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- Today Dosecann, an...
XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program
EMERYVILLE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has...
Sonnet BioTherapeutics Completes Licensing Agreement with New Life Therapeutics
New Life Therapeutics (NLT) to develop low-dose Interleukin 6 for Diabetic Peripheral Neuropathy in ASEAN territories Upfront and potential milestone...
Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021
AC – Inflammation was Mild and Decreasing over Time in Cohort 3 AC – Inflammation was Mild and Decreasing over...
Oyster Point Pharma Announces Clinical Data Presentation of OC-01 (varenicline) Nasal Spray for Dry Eye Disease at the Association for Research in Vision and Ophthalmology 2021 Virtual Annual Meeting
PRINCETON, N.J., May 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on...
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
Treatment with BIIB122/DNL151 achieved robust reductions in biomarkers of target engagement and pathway engagement in healthy volunteers and patients with...